The Scientific World Journal / 2012 / Article / Tab 2

Research Article

Impact of Cypermethrin on Fingerlings of Common Edible Carp (Labeo rohita)

Table 2

Exposure of fish Labeo rohita fingerlings to cypermethrin for 24 h exposure periods.

ParametersTissuesControlDoses
0.129 μg/L (40% of 6 h LC50)0.258 μg/L (80% of 6 h LC50)

TPLiver 1 2 0 . 1 0 ± 0 . 1 0 (100) 1 0 8 . 0 9 ± 0 . 1 2 (90)abc 9 6 . 0 8 ± 0 . 1 4 (80)abc
Muscle 1 3 0 . 0 0 ± 0 . 2 2 (100) 1 1 4 . 4 0 ± 0 . 1 4 (88)abc 9 4 . 9 0 ± 0 . 2 2 (73)abc
FAALiver 7 . 1 0 ± 0 . 3 0 (100) 8 . 5 2 ± 0 . 1 9 (120)bc 9 . 9 4 ± 0 . 1 4 (140)abc
Muscle 1 3 . 2 5 ± 0 . 2 0 (100) 1 7 . 8 8 ± 0 . 1 9 (135)abc 2 0 . 5 4 ± 0 . 1 3 (155)abc
DNALiver 3 5 . 4 0 ± 0 . 2 2 (100) 3 1 . 8 6 ± 0 . 1 3 (90)abc 2 8 . 3 2 ± 0 . 1 2 (80)abc
Muscle 3 . 2 0 ± 0 . 3 6 (100) 2 7 . 5 6 ± 0 . 2 2 (83)abc 2 3 . 2 4 ± 0 . 2 2 (70)abc
RNALiver 3 7 . 4 4 ± 0 . 3 3 (100) 2 9 . 9 5 ± 0 . 4 1 (80)abc 2 5 . 8 3 ± 0 . 2 1 (69)abc
Muscle 3 8 . 3 5 ± 0 . 1 5 (100) 2 5 . 6 9 ± 0 . 1 6 (67)abc 2 0 . 3 3 ± 0 . 2 3 (53)abc
GYLiver 2 . 1 0 ± 0 . 0 5 (100) 2 . 0 0 ± 0 . 0 6 (95)c 1 . 7 0 ± 0 . 0 1 (81)abc
Muscle 1 . 7 0 ± 0 . 0 2 (100) 1 . 5 3 ± 0 . 0 5 (90)abc 1 . 3 4 ± 0 . 0 5 (79)abc
PYLiver 1 . 9 9 ± 0 . 0 2 (100) 1 . 3 9 ± 0 . 0 6 (70)ab 1 . 2 7 ± 0 . 0 8 (64)ab
Muscle 1 . 5 0 ± 0 . 0 1 (100) 1 . 1 6 ± 0 . 0 2 (77)ab 0 . 9 8 ± 0 . 0 4 (65)ab
LALiver 1 . 4 4 ± 0 . 0 3 (100) 1 . 5 8 ± 0 . 0 9 (110)bc 1 . 8 7 ± 0 . 0 3 (130)abc
Muscle 1 . 2 5 ± 0 . 0 1 (100) 1 . 4 4 ± 0 . 0 3 (115)abc 1 . 8 1 ± 0 . 0 5 (145)abc
PRLiver 0 . 4 6 3 0 ± 0 . 0 1 (100) 0 . 5 3 2 5 ± 0 . 0 2 (115)bc 0 . 6 0 1 9 ± 0 . 0 6 (130)abc
Muscle 0 . 3 3 4 0 ± 0 . 0 4 (100) 0 . 4 0 0 8 ± 0 . 0 6 (120)bc 0 . 5 0 1 0 ± 0 . 0 2 (150)abc
ACLiver 0 . 1 3 5 ± 0 . 0 0 6 (100) 0 . 1 1 9 ± 0 . 0 0 2 (88)abc 0 . 0 9 5 ± 0 . 0 0 4 (70)abc
Muscle 0 . 1 3 1 ± 0 . 0 0 4 (100) 0 . 0 9 3 ± 0 . 0 0 3 (71)abc 0 . 0 7 7 ± 0 . 0 0 8 (59)abc
AKLiver 0 . 4 7 9 ± 0 . 0 0 7 (100) 0 . 4 3 1 ± 0 . 0 0 4 (90)abc 0 . 3 8 3 ± 0 . 0 0 3 (80)abc
Muscle 0 . 4 6 5 ± 0 . 0 0 9 (100) 0 . 3 8 1 ± 0 . 0 0 6 (82)abc 0 . 3 3 0 ± 0 . 0 0 3 (71)abc
ALATLiver 3 . 4 6 ± 0 . 3 0 (100) 4 . 2 2 ± 0 . 2 2 (122)abc 4 . 9 1 ± 0 . 1 5 (142)abc
Muscle 2 . 7 6 ± 0 . 1 1 (100) 3 . 3 1 ± 0 . 1 0 (120)abc 4 . 1 4 ± 0 . 1 3 (150)abc
AAT Liver 1 . 8 0 ± 0 . 0 9 (100) 2 . 0 7 ± 0 . 0 7 (115)bc 2 . 4 3 ± 0 . 0 8 (135)abc
Muscle 1 . 4 4 ± 0 . 0 8 (100) 1 . 5 8 ± 0 . 0 6 (110)bc 2 . 1 0 ± 0 . 0 5 (146)abc
AChE Liver 0 . 1 7 0 ± 0 . 0 3 (100) 0 . 0 9 4 ± 0 . 0 2 (55)abc 0 . 0 6 8 ± 0 . 0 1 (40)abc
Muscle 0 . 1 9 0 ± 0 . 0 4 (100) 0 . 1 1 4 ± 0 . 0 3 (60)ab 0 . 0 8 2 ± 0 . 0 1 (43)ab
CyO Liver 3 5 . 3 0 ± 0 . 2 0 (100) 2 8 . 2 4 ± 0 . 1 0 (80)abc 2 4 . 7 1 ± 0 . 1 0 (70)abc
Muscle 3 3 . 4 4 ± 0 . 4 0 (100) 2 5 . 0 8 ± 0 . 2 3 (75)abc 2 1 . 0 7 ± 0 . 1 2 (63)abc

Values were mean ± SE of six replicates.
Values in parentheses were % change with control taken as 100%.
Student’s “ 𝑡 ” test shows asignificant value ( 𝑃 < 0 . 0 5 ), when treated groups were compared with controls.
ANOVA and LSD test show significant ( 𝑃 < 0 . 0 5 ), when btreated groups were compared with controls and ctreated groups were compared with each other.
Total protein (TP), total free amino acids (FAA), pyruvate (PY), lactate (LA), glycogen (GY), protease (PR), acid phosphatase (AC), alkaline phosphatase (AK), alanine aminotransferase (ALAT), aspartate aminotransferase (AAT), acetylcholinesterase (AChE), and cytochrome oxidase (CyO).

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.